Your browser doesn't support javascript.
loading
In vivo efficacy & resistance prevention of cefiderocol in combination with ceftazidime/avibactam, ampicillin/sulbactam or meropenem using human-simulated regimens versus Acinetobacter baumannii.
Gill, Christian M; Santini, Debora; Takemura, Miki; Longshaw, Christopher; Yamano, Yoshinori; Echols, Roger; Nicolau, David P.
Afiliação
  • Gill CM; Center for Anti-Infective Research and Development, Hartford Hospital, 80 Seymour Street, Hartford, CT 06102, USA.
  • Santini D; Center for Anti-Infective Research and Development, Hartford Hospital, 80 Seymour Street, Hartford, CT 06102, USA.
  • Takemura M; Research Planning Department, Shionogi & Co., Ltd, 3-1-1, Futaba-cho, Toyonaka,Osaka 561-0825, Japan.
  • Longshaw C; Scientific Affairs, Shionogi B.V., 33 Kingsway, London, WC2B 6UF, UK.
  • Yamano Y; Research Planning Department, Shionogi & Co., Ltd, 3-1-1, Futaba-cho, Toyonaka,Osaka 561-0825, Japan.
  • Echols R; Infectious Disease Drug Development Consulting, LLC, 753 Westport Road, Easton, CT, USA.
  • Nicolau DP; Center for Anti-Infective Research and Development, Hartford Hospital, 80 Seymour Street, Hartford, CT 06102, USA.
J Antimicrob Chemother ; 78(4): 983-990, 2023 04 03.
Article em En | MEDLINE | ID: mdl-36775993
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ceftazidima / Acinetobacter baumannii Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ceftazidima / Acinetobacter baumannii Idioma: En Ano de publicação: 2023 Tipo de documento: Article